250 related articles for article (PubMed ID: 23578094)
21. Parainfluenza virus 5-based vaccine vectors expressing vaccinia virus (VACV) antigens provide long-term protection in mice from lethal intranasal VACV challenge.
Clark KM; Johnson JB; Kock ND; Mizel SB; Parks GD
Virology; 2011 Oct; 419(2):97-106. PubMed ID: 21885079
[TBL] [Abstract][Full Text] [Related]
22. Expanding the repertoire of Modified Vaccinia Ankara-based vaccine vectors via genetic complementation strategies.
Garber DA; O'Mara LA; Zhao J; Gangadhara S; An I; Feinberg MB
PLoS One; 2009; 4(5):e5445. PubMed ID: 19421328
[TBL] [Abstract][Full Text] [Related]
23. Fowlpoxvirus recombinants coding for the CIITA gene increase the expression of endogenous MHC-II and Fowlpox Gag/Pro and Env SIV transgenes.
Bissa M; Forlani G; Zanotto C; Tosi G; De Giuli Morghen C; Accolla RS; Radaelli A
PLoS One; 2018; 13(1):e0190869. PubMed ID: 29385169
[TBL] [Abstract][Full Text] [Related]
24. Clinical development of Modified Vaccinia virus Ankara vaccines.
Gilbert SC
Vaccine; 2013 Sep; 31(39):4241-6. PubMed ID: 23523410
[TBL] [Abstract][Full Text] [Related]
25. Construction of a recombinant avipoxvirus expressing the env gene of Zika virus as a novel putative preventive vaccine.
Zanotto C; Paolini F; Radaelli A; De Giuli Morghen C
Virol J; 2021 Mar; 18(1):50. PubMed ID: 33663531
[TBL] [Abstract][Full Text] [Related]
26. Subunit recombinant vaccine protects against monkeypox.
Heraud JM; Edghill-Smith Y; Ayala V; Kalisz I; Parrino J; Kalyanaraman VS; Manischewitz J; King LR; Hryniewicz A; Trindade CJ; Hassett M; Tsai WP; Venzon D; Nalca A; Vaccari M; Silvera P; Bray M; Graham BS; Golding H; Hooper JW; Franchini G
J Immunol; 2006 Aug; 177(4):2552-64. PubMed ID: 16888017
[TBL] [Abstract][Full Text] [Related]
27. Immunization with a single extracellular enveloped virus protein produced in bacteria provides partial protection from a lethal orthopoxvirus infection in a natural host.
Fang M; Cheng H; Dai Z; Bu Z; Sigal LJ
Virology; 2006 Feb; 345(1):231-43. PubMed ID: 16256161
[TBL] [Abstract][Full Text] [Related]
28. Construction of recombinant fowlpox viruses as vectors for poultry vaccines.
Boyle DB; Coupar BE
Virus Res; 1988 Jun; 10(4):343-56. PubMed ID: 2842977
[TBL] [Abstract][Full Text] [Related]
29. A vaccinia virus renaissance: new vaccine and immunotherapeutic uses after smallpox eradication.
Verardi PH; Titong A; Hagen CJ
Hum Vaccin Immunother; 2012 Jul; 8(7):961-70. PubMed ID: 22777090
[TBL] [Abstract][Full Text] [Related]
30. An attenuated LC16m8 smallpox vaccine: analysis of full-genome sequence and induction of immune protection.
Morikawa S; Sakiyama T; Hasegawa H; Saijo M; Maeda A; Kurane I; Maeno G; Kimura J; Hirama C; Yoshida T; Asahi-Ozaki Y; Sata T; Kurata T; Kojima A
J Virol; 2005 Sep; 79(18):11873-91. PubMed ID: 16140764
[TBL] [Abstract][Full Text] [Related]
31. Third-generation smallpox vaccine strain-based recombinant vaccines for viral hemorrhagic fevers.
Yoshikawa T
Vaccine; 2021 Oct; 39(41):6174-6181. PubMed ID: 34521550
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the immunogenicity and protective efficacy of ACAM2000, MVA, and vectored subunit vaccines for Mpox in rhesus macaques.
Jacob-Dolan C; Ty D; Hope D; McMahan K; Liu J; Powers OC; Cotter CA; Sciacca M; Wu C; Borducchi E; Bouffard E; Richter H; Velasco J; Teow E; Boursiquot M; Cook A; Feliciano K; Yalley-Ogunro J; Seaman MS; Pessiant L; Lewis MG; Andersen H; Moss B; Barouch DH
Sci Transl Med; 2024 Mar; 16(740):eadl4317. PubMed ID: 38536937
[TBL] [Abstract][Full Text] [Related]
33. Heterogeneity in the A33 protein impacts the cross-protective efficacy of a candidate smallpox DNA vaccine.
Golden JW; Hooper JW
Virology; 2008 Jul; 377(1):19-29. PubMed ID: 18482742
[TBL] [Abstract][Full Text] [Related]
34. The immune response to vaccinia virus is significantly reduced after scarification with TK- recombinants as compared to wild-type virus.
Phillpotts RJ; Lescott T; Gates AJ; Jones L
Acta Virol; 2000; 44(3):151-6. PubMed ID: 11155357
[TBL] [Abstract][Full Text] [Related]
35. Construction and characterisation of a recombinant fowlpox virus that expresses the human papilloma virus L1 protein.
Zanotto C; Pozzi E; Pacchioni S; Bissa M; De Giuli Morghen C; Radaelli A
J Transl Med; 2011 Nov; 9():190. PubMed ID: 22053827
[TBL] [Abstract][Full Text] [Related]
36. Antibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin.
Bell E; Shamim M; Whitbeck JC; Sfyroera G; Lambris JD; Isaacs SN
Virology; 2004 Aug; 325(2):425-31. PubMed ID: 15246280
[TBL] [Abstract][Full Text] [Related]
37. Immunomodulator-based enhancement of anti smallpox immune responses.
Martínez O; Miranda E; Ramírez M; Santos S; Rivera C; Vázquez L; Sánchez T; Tremblay RL; Ríos-Olivares E; Otero M
PLoS One; 2015; 10(4):e0123113. PubMed ID: 25875833
[TBL] [Abstract][Full Text] [Related]
38. A protein-based smallpox vaccine protects mice from vaccinia and ectromelia virus challenges when given as a prime and single boost.
Xiao Y; Aldaz-Carroll L; Ortiz AM; Whitbeck JC; Alexander E; Lou H; Davis HL; Braciale TJ; Eisenberg RJ; Cohen GH; Isaacs SN
Vaccine; 2007 Jan; 25(7):1214-24. PubMed ID: 17098336
[TBL] [Abstract][Full Text] [Related]
39. Selection of Vaccinia Virus-Neutralizing Antibody from a Phage-Display Human-Antibody Library.
Shin YW; Chang KH; Hong GW; Yeo SG; Jee Y; Kim JH; Oh MD; Cho DH; Kim SH
J Microbiol Biotechnol; 2019 Apr; 29(4):651-657. PubMed ID: 30856707
[TBL] [Abstract][Full Text] [Related]
40. Pox viruses as eukaryotic cloning and expression vectors: future medical and veterinary vaccines.
Taylor J; Paoletti E
Prog Vet Microbiol Immunol; 1988; 4():197-217. PubMed ID: 3078866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
